Additionally, comprehensive metabolomic profiling of human lung cancer cells has shown that NRF2 also controls the serine biosynthesis metabolic program via activating transcription factor 4 (ATF4) and phosphoglycerate dehydrogenase activation [76]. The gene discussed is NFE2L2; the disease is lung carcinoma.